home / stock / bayry / bayry articles


BAYRY Articles, Bayer AG ADR - From 03/05/24

Stock Information

Company Name: Bayer AG ADR
Stock Symbol: BAYRY
Market: OTC

Menu

BAYRY BAYRY Quote BAYRY Short BAYRY News BAYRY Articles BAYRY Message Board
Get BAYRY Alerts

News, Short Squeeze, Breakout and More Instantly...

Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges | Benzinga

Bayer AG (OTC:BAYRY) (OTC:BAYZF) will hold off on plans to break the group, the new CEO Bill Anderson said. On the question of the c...

What's Going On With BridgeBio Pharma Stock On Monday? | Benzinga

Monday, BridgeBio Pharma Inc (NASDAQ:BBIO) and Bayer AG (OTC:BAYRY) (OTC:BAYZF) announced a partnership wherein BridgeBio grant...

Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial | Benzinga

In a pivotal moment for Australia, an Australian court heard closing arguments on Tuesday in a class action lawsuit against Bayer AG ...

Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout | Benzinga

A Pennsylvania jury has ordered Bayer AG’s (OTC:BAYRY) (OTC:BAYZF) Monsanto to pay over $2.2 billion to former Roundup us...

Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo and Lilly's Dominance | Benzinga

Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positionin...

Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance | Benzinga

Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positionin...

Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial | Benzinga

Monday, Bayer AG (OTC: BAYRY (OTC: BAYZF) announced topline results of Phase 3 studies OASIS 1 and 2 evaluating the efficacy an...

Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial | Benzinga

Bayer AG (OTC:BAYRY) (OTC:BAYZF) and Asklepios BioPharmaceutical Inc completed an 18-month data collection in the Phase Ib trial for AB-1005 (AAV2...

Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak | Benzinga

In a significant turn of events, Bayer AG (OTC: BAYRY) (OTC: BAYZF) emerged victorious in a California lawsuit filed by Bruce Jones, who ...

Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss | Benzinga

Bayer AG (OTC: BAYRY) (OTC: BAYZF) encountered another setback in its ongoing legal battles related to its Roundup weedkiller after ...

Previous 10 Next 10